{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:25:51Z","timestamp":1780370751719,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R34MH114664"],"award-info":[{"award-number":["R34MH114664"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s41669-025-00569-z","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:43:36Z","timestamp":1744235016000},"page":"649-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-Effectiveness of Using Conditional Economic Incentives to Improve Pre-exposure Prophylaxis Adherence Among Male Sex Workers"],"prefix":"10.1007","volume":"9","author":[{"given":"Carlos","family":"Chivardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-5585","authenticated-orcid":false,"given":"Alejandro","family":"Zamudio-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-7142","authenticated-orcid":false,"given":"Marta","family":"Wilson-Barthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alarid-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Operario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-9266","authenticated-orcid":false,"given":"Omar","family":"Gal\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"569_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s10461-022-03809-z","volume":"27","author":"AB Algarin","year":"2023","unstructured":"Algarin AB, Lara MV, Chapin-Bardales J, Baruch-Dominguez R, Sanchez TH, Hernandez-Avila M, et al. Examining geographical differences in the HIV care continuum among men who have sex with men in Mexico. AIDS Behav. 2023;27:772\u201382.","journal-title":"AIDS Behav"},{"key":"569_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072616","volume":"8","author":"S Bautista-Arredondo","year":"2013","unstructured":"Bautista-Arredondo S, Colchero MA, Romero M, Conde-Glez CJ, Sosa-Rub\u00ed SG. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PLoS ONE. 2013;8: e72616.","journal-title":"PLoS ONE"},{"key":"569_CR3","doi-asserted-by":"crossref","unstructured":"Ganley KY, Wilson-Barthes M, Zullo AR, Sosa-Rub\u00ed SG, Conde-Glez CJ, Garc\u00eda-Cisneros S, et al. Incidence and time-varying predictors of HIV and sexually transmitted infections among male sex workers in Mexico City. Infect Dis Poverty. 2021;10:36\u201345.","DOI":"10.1186\/s40249-020-00792-2"},{"key":"569_CR4","doi-asserted-by":"crossref","unstructured":"Biello KB, Oldenburg CE, Mitty JA, Closson EF, Mayer KH, Safren SA, et al. The \u201csafe sex\u201d conundrum: anticipated stigma from sexual partners as a barrier to PrEP use among substance using MSM engaging in transactional sex. AIDS Behav. 2017;21:300\u2013306.","DOI":"10.1007\/s10461-016-1466-y"},{"key":"569_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1257\/aer.103.3.445","volume":"103","author":"M Shah","year":"2013","unstructured":"Shah M. Do sex workers respond to disease? Evidence from the male market for sex. Am Econ Rev. 2013;103:445\u201350.","journal-title":"Am Econ Rev"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijid.2018.08.006","volume":"75","author":"D Qu","year":"2018","unstructured":"Qu D, Zhong X, Xiao G, Dai J, Liang H, Huang A. Adherence to pre-exposure prophylaxis among men who have sex with men: a prospective cohort study. Int J Infect Dis. 2018;75:52\u20139.","journal-title":"Int J Infect Dis"},{"key":"569_CR7","doi-asserted-by":"crossref","unstructured":"Chemnasiri T, Varangrat A, Amico KR, Chitwarakorn A, Dye BJ, Grant RM, et al. Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067\/ADAPT study. AIDS Care. 2020;32.","DOI":"10.1080\/09540121.2019.1623374"},{"key":"569_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14:820\u20139.","journal-title":"Lancet Infect Dis"},{"key":"569_CR9","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Switzerland; 2015."},{"key":"569_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1089\/apc.2014.0195","volume":"28","author":"AY Liu","year":"2014","unstructured":"Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, et al. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDS. 2014;28:622\u20137.","journal-title":"AIDS Patient Care STDS"},{"key":"569_CR11","volume-title":"Male sex workers","author":"O Gal\u00e1rraga","year":"2016","unstructured":"Gal\u00e1rraga O, Sosa-Rub\u00ed SG. Male sex workers. Oxford University Press; 2016."},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S2352-3018(22)00331-9","volume":"10","author":"VG Veloso","year":"2023","unstructured":"Veloso VG, C\u00e1ceres CF, Hoagland B, Moreira RI, Vega-Ram\u00edrez H, Konda KA, et al. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study. Lancet HIV. 2023;10:e84-96.","journal-title":"Lancet HIV."},{"key":"569_CR13","doi-asserted-by":"crossref","unstructured":"Linnemayr S, MacCarthy S. Using behavioral economics to promote HIV prevention for key populations. J AIDS Clin Res. 2018;9(11):780.","DOI":"10.4172\/2155-6113.1000780"},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10461-019-02425-8","volume":"24","author":"Z Wagner","year":"2020","unstructured":"Wagner Z, Montoy JCC, Drabo EF, Dow WH. Incentives versus defaults: cost-effectiveness of behavioral approaches for HIV screening. AIDS Behav. 2020;24:379\u201386.","journal-title":"AIDS Behav"},{"key":"569_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.115684","volume":"320","author":"SP Masiano","year":"2023","unstructured":"Masiano SP, Kawende B, Ravelomanana NLR, Green TL, Dahman B, Thirumurthy H, et al. Economic costs and cost-effectiveness of conditional cash transfers for the uptake of services for the prevention of vertical HIV transmissions in a resource-limited setting. Soc Sci Med. 2023;320: 115684.","journal-title":"Soc Sci Med"},{"key":"569_CR16","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1016\/S2214-109X(17)30296-6","volume":"5","author":"EL Sibanda","year":"2017","unstructured":"Sibanda EL, Tumushime M, Mufuka J, Mavedzenge SN, Gudukeya S, Bautista-Arredondo S, et al. Effect of non-monetary incentives on uptake of couples\u2019 counselling and testing among clients attending mobile HIV services in rural Zimbabwe: a cluster-randomised trial. Lancet Glob Health. 2017;5:e907\u201315.","journal-title":"Lancet Glob Health"},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2352-3018(17)30176-5","volume":"5","author":"K Kranzer","year":"2018","unstructured":"Kranzer K, Simms V, Bandason T, Dauya E, McHugh G, Munyati S, et al. Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trial. Lancet HIV. 2018;5:e79-86.","journal-title":"Lancet HIV."},{"key":"569_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jama.2014.9087","volume":"312","author":"H Thirumurthy","year":"2014","unstructured":"Thirumurthy H, Masters SH, Rao S, Bronson MA, Lanham M, Omanga E, et al. Effect of providing conditional economic compensation on uptake of voluntary medical male circumcision in Kenya. JAMA. 2014;312:703.","journal-title":"JAMA"},{"key":"569_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-024-01705-y","author":"O Gal\u00e1rraga","year":"2024","unstructured":"Gal\u00e1rraga O, Wilson-Barthes M, Chivardi C, Gras-Allain N, Alarid-Escudero F, Gandhi M, et al. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico. Euro J Health Econ. 2024. https:\/\/doi.org\/10.1007\/s10198-024-01705-y.","journal-title":"Euro J Health Econ."},{"key":"569_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03443-1","author":"A Salinas-Rodr\u00edguez","year":"2021","unstructured":"Salinas-Rodr\u00edguez A, Sosa-Rub\u00ed SG, Chivardi C, Rodr\u00edguez-Franco R, Gandhi M, Mayer KH, et al. Preferences for conditional economic incentives to improve pre-exposure prophylaxis adherence: a discrete choice experiment among male sex workers in Mexico. AIDS Behav. 2021. https:\/\/doi.org\/10.1007\/s10461-021-03443-1.","journal-title":"AIDS Behav"},{"key":"569_CR21","unstructured":"The Word Bank. Official exchange rate (LCU per US$, period average) - Mexico. 2023. https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF?locations=MX. Accessed 26 Jun 2023."},{"key":"569_CR22","unstructured":"Centro para el Control y Prevenci\u00f3n de Enfermedades. Prep Effectiveness. 2022. https:\/\/www.cdc.gov\/hiv\/spanish\/basics\/prep\/prep-effectiveness.html. Accessed 13 Mar 2024."},{"key":"569_CR23","doi-asserted-by":"crossref","unstructured":"Anderson PL, Glidden D V., Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):125\u2013151.","DOI":"10.1126\/scitranslmed.3004006"},{"key":"569_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/QAI.0b013e3182973966","volume":"64","author":"PG Farnham","year":"2013","unstructured":"Farnham PG, Gopalappa C, Sansom SL, Hutchinson AB, Brooks JT, Weidle PJ, et al. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States. JAIDS J Acquir Immune Defic Syndr. 2013;64:183\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"key":"569_CR25","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/QAI.0b013e3182a5c8d4","volume":"64","author":"PG Farnham","year":"2013","unstructured":"Farnham PG, Holtgrave DR, Gopalappa C, Hutchinson AB, Sansom SL. Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era. JAIDS J Acquir Immune Defic Syndr. 2013;64:e15\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"key":"569_CR26","unstructured":"The Word Bank. GDP per capita (current US$)-Mexico. 2023. https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=MX. Accessed 26 Jun 2023."},{"key":"569_CR27","volume-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"RMPM Baltussen","year":"2023","unstructured":"Baltussen RMPM, Adam T, Tan-Torres Edejer T, Hutubessy RCW, Acharya A, Evans DB, et al. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2023."},{"key":"569_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","volume":"19","author":"B Woods","year":"2016","unstructured":"Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value in Health. 2016;19:929\u201335.","journal-title":"Value in Health."},{"key":"569_CR29","unstructured":"Alarid-Escudero F, Knowlton G, Easterly C, Enns E. Decision analytic modeling package (dampack). 2012."},{"key":"569_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(17)30540-6","volume":"18","author":"V Cambiano","year":"2018","unstructured":"Cambiano V, Miners A, Dunn D, McCormack S, Ong KJ, Gill ON, et al. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation. Lancet Infect Dis. 2018;18:85\u201394.","journal-title":"Lancet Infect Dis"},{"key":"569_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.7326\/M21-1548","volume":"175","author":"AM Neilan","year":"2022","unstructured":"Neilan AM, Landovitz RJ, Le MH, Grinsztejn B, Freedberg KA, McCauley M, et al. Cost-Effectiveness of long-acting injectable HIV preexposure prophylaxis in the United States. Ann Intern Med. 2022;175:479\u201389.","journal-title":"Ann Intern Med"},{"key":"569_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11904-022-00624-y","volume":"19","author":"U Roy Paladhi","year":"2022","unstructured":"Roy Paladhi U, Katz DA, Farquhar C, Thirumurthy H. Using behavioral economics to support PrEP adherence for HIV prevention. Curr HIV\/AIDS Rep. 2022;19:409\u201314.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"569_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40258-021-00658-0","volume":"19","author":"C Gutierrez-Delgado","year":"2021","unstructured":"Gutierrez-Delgado C, Galindo-Su\u00e1rez R-M, Cruz-Santiago C, Shah K, Papadimitropoulos M, Feng Y, et al. EQ-5D-5L Health-state values for the Mexican population. Appl Health Econ Health Policy. 2021;19:905\u201314.","journal-title":"Appl Health Econ Health Policy"}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-025-00569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41669-025-00569-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-025-00569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:26:40Z","timestamp":1751275600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41669-025-00569-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s41669-025-00569-z","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"value":"2509-4262","type":"print"},{"value":"2509-4254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"23 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was partially funded by the National Institute of Mental Health of the National Institutes of Health under award no. R34MH114664, with general support from the Brown University Population Studies and Training Center (P2CHD041020). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The code supporting the findings of this study is available upon reasonable request from the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All study protocols and materials implemented during the PrEP Seguro randomized pilot trial were approved by the ethics committees at Brown University (IRB Authorization Agreement no. 18\u201370) and Instituto Nacional de Salud P\u00fablica (INSP, National Institute of Public Health) in Mexico (protocol no. P33-18, project CI: 1551).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Aspects"}},{"value":"All trial participants provided written informed consent for study participation.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All trial participants provided written informed consent to the use of their data for research purposes.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication (from patients\/participants)"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"ClinicalTrials.gov identifier: NCT03674983.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}},{"value":"O.G. obtained the funding, leading to the research presented in this publication. O.G. and C.C. made substantial contributions to the conception or design of the work and to the analysis and interpretation of data for the work. F.A.E., M.W.B., and A.Z.S. made substantial contributions to the analysis or interpretation of data for the work. C.C. drafted the work. O.G., F.A.E., M.W.B., A.Z.S., M.G., K.H.M., and D.O. revised the work critically for important intellectual content. All authors gave final approval for the version to be published and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}